India-based cancer specialty hospital HCGMCC launches clinic to raise hereditary cancer awareness & offer lifesaving family screening

23rd September, 2024

Clinic prioritizes early detection; expert-led personalized cancer treatment plans in oncology & genetics

India-based cancer speciality hospital - HCG Manavata Cancer Centre (HCGMCC) has launched 'Vansham Clinic' to address the growing need for hereditary cancer awareness and early intervention. This new clinic offers specialized screening and preventive measures for individuals with a family history of cancer. With the rise in cancer cases in India, this initiative aims to bridge the knowledge gap and provide tailored healthcare solutions focusing on early detection and personalized treatment plans, potentially saving lives and reducing the future burden of cancer.

Vansham clinic operates with a highly specialized team, including experienced genetic counsellors and oncologists, ensuring personalized care from initial consultation to long-term follow-up. Appointments are available for individuals and families, providing a holistic approach that prioritizes education, prevention and patient empowerment. Vansham Clinic will focus on providing targeted screenings for hereditary cancers, including breast, ovarian and colorectal cancers. Additionally, the team of medical professionals will offer lifestyle counselling to help patients make informed decisions about their health and lifestyle choices to lower cancer risk. Early detection is crucial in the fight against cancer, enabling to offer less invasive treatments, reduce healthcare costs and ultimately, improve patient outcomes.

“Our attempt with the launch of Vansham Clinic is to address the growing need for awareness and management of hereditary cancers. Many families remain unaware of their genetic predisposition, missing crucial opportunities for early diagnosis and intervention. The clinic aims to close this gap by offering advanced genetic counselling, targeted screenings, and preventive healthcare for those at risk,” said Dr Raj Nagarkar, MD & Chief of Surgical Oncology & Robotic Services, HCG Manavata Cancer Centre (HCGMCC).

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer